Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Refractory, with Excess of Blasts × Watchful Waiting × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Colonic Neoplasms 4 Carcinoma, Renal Cell 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Uterine Cervical Dysplasia 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Ureteral Neoplasms 1 Thyroid Nodule 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Smoldering Multiple Myeloma 1 Retinoblastoma 1 Precancerous Conditions 1 Pleuropulmonary blastoma 1

Interventions

Cyclophosphamide 15 fludarabine phosphate 12 Whole-Body Irradiation 12 Mycophenolic Acid 12 fludarabine 11 Tacrolimus 8 Peripheral Blood Stem Cell Transplantation 8 Busulfan 8 Melphalan 7 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Azacitidine 5 Filgrastim 4 venetoclax 3 Cord Blood Stem Cell Transplantation 3 Biopsy 3 thymoglobulin 2 decitabine and cedazuridine drug combination 2 Vorinostat 2 Thiotepa 2 Specimen Handling 2 Sirolimus 2 Rituximab 2 Methotrexate 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 Cyclosporins 2 Clofarabine 2 Bone Marrow Transplantation 2 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡